(E)-p-coumaroylagmatine

Metabolite details

Identifier

AKIHYQWCLCDMMI-VMPITWQZSA-N

InChI Key

AKIHYQWCLCDMMI-VMPITWQZSA-N

IUPAC name

(2E)-N-[4-(carbamimidamido)butyl]-3-(4-hydroxyphenyl)prop-2-enamide

Preferred name

(E)-p-coumaroylagmatine

INN name

—

Synonym

(E)-N-(4-guanidinobutyl)-4-hydroxycinnamamide

ChEBI

CHEBI:86080

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Metabolomic Insights into the Browning of the Peel of Bagging ‘Rui Xue’ Apple Fruit
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 21)
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Non_Bagged_Fruits_vs_Bagged_Fruits_With_Browning
• Control_vs_nsPEF_7_day
• Control_vs_Lithogenic_Diet
• Sham_vs_UIR
• Normal_vs_Neural_Tube_Defect
• Control_vs_CSD